Cited by 172Immunotherapy and Immune ResponsesImmune responses and vaccinationsvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Novel vaccine technologies for the 21st century

Open access

Mascola, John R., Fauci, Anthony S.·2020·Nature Reviews Immunology

DOI 10.1038/s41577-019-0243-3PMC PMC7222935

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41577-019-0243-3

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Nemes, E., Geldenhuys, H. D., Rozot, V., Rutkowski, K. T., Ratangee, F., Bilek, N., Mabwe, S., Makhethe, L., Erasmus, M., Toefy, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714021 · Cited by 653
Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Tait, D. R., Hatherill, M., Van Der Meeren, O., Ginsberg, A. M., Van Brakel, E., Salaun, B., Scriba, T. J., Akite, E. J., Ayles, H. M., Bollaerts, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1909953 · Cited by 605
Prevention of tuberculosis in macaques after intravenous BCG immunization
Darrah, P. A., Zeppa, J. J., Maiello, P. A., Hackney, J. A., Wadsworth, M. H., Hughes, T. K., Pokkali, S., Swanson, P. A., Grant, N. L., Rodgers, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1817-8 · Cited by 592
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Feldman, R. A., Fuhr, R., Smolenov, I., (Mick) Ribeiro, A., Panther, L., Watson, M., Senn, J. J., Smith, M., Almarsson, Ӧ., Pujar, H. S., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.074 · Cited by 454
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E. A., Benhaim, M. A., Ravichandran, R., Carter, L. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 444
A proof of concept for structure-based vaccine design targeting RSV in humans
Crank, M. C., Ruckwardt, T. J., Chen, M., Morabito, K. M., Phung, E., Costner, P. J., Holman, L. A., Hickman, S. P., Berkowitz, N. M., Gordon, I. J., et al. (2019) · Science · doi:10.1126/science.aav9033 · Cited by 333
Self-citation
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Pardi, N., Parkhouse, K., Kirkpatrick, E., McMahon, M., Zost, S. J., Mui, B. L., Tam, Y. K., Karikó, K., Barbosa, C. J., Madden, T. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05482-0 · Cited by 281
Designing Tomorrow's Vaccines
Nabel, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204186 · Cited by 271
Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine
Paules, C. I., Sullivan, S. G., Subbarao, K., & Fauci, A. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1714916 · Cited by 256
Self-citation
New Promise for Vaccines against Tuberculosis
Bloom, B. R. (2018) · New England Journal of Medicine · doi:10.1056/nejme1812483 · Cited by 27

Show all 10 references

Research works printed but not linked: 1

Darrah, P. A. et al. Prevention of tuberculosis in nonhuman primates following intravenous BCG immunization. Nature (in the press).

Sorted by citations

Items 101–172 of 172

Synthetic vaccines targeting Mincle through conjugation of trehalose dibehenate
Hanna, C. C., Maxwell, J. W. C., Ismanto, H. S., Ashhurst, A. S., Artner, L. M., Rudrawar, S., Britton, W. J., Yamasaki, S., & Payne, R. J. (2022) · Chemical Communications · doi:10.1039/d2cc02100e · Cited by 7
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
Li, J., Long, H., Chen, S., Zhang, Z., Li, S., Liu, Q., Liu, J., Cai, J., Luo, L., & Peng, Y. (2025) · Vaccines · doi:10.3390/vaccines13010052 · Cited by 7
Continuous purification of mRNA by precipitation and sequential TFF
Royo, M. D. C. P., Arnold, T., Rodriguez, I. P., Ostrovsky, N., Al‐Jazrawe, M., Hatas, A., Myerson, A. S., & Braatz, R. D. (2025) · Separation and Purification Technology · doi:10.1016/j.seppur.2025.134837 · Cited by 6
Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation
Wang, S., Jiang, T., Jiang, M., & Miao, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102300 · Cited by 7
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Chen, G., Yu, X., Luo, L., Zhang, F., Dai, X.-H., Li, N., Shen, Z.-W., Wu, K.-Q., Lou, D., Peng, C.-G., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.10.065 · Cited by 6
New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement
Buck, P. O., Gomes, D. A., Beck, E. C., Kirson, N. Y., Mattera, M., Carroll, S., Ultsch, B., Jayasundara, K., Uhart, M., & Garrison, L. P. (2024) · Vaccines · doi:10.3390/vaccines12030234 · Cited by 6
Chimeric antigen carried by extracellular vesicles induces stronger protective immunity against Mycobacterium tuberculosis infection
Lin, J., Fu, Y., & Xiong, S. (2024) · Immunobiology · doi:10.1016/j.imbio.2024.152834 · Cited by 6
Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo
Terry, T. L., Givens, B. E., Adamcakova‐Dodd, A., Thorne, P. S., Rodgers, V. G. J., & Salem, A. K. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01932-z · Cited by 7
RNA-based nanomedicines and their clinical applications
Su, L.-J., Ji, Z.-H., Xu, M.-X., Zhu, J.-Q., Chen, Y., Qiao, J.-F., Wang, Y., & Lin, Y. (2023) · Nano Research · doi:10.1007/s12274-023-6238-5 · Cited by 7
Enhanced Immune Responses by Virus-Mimetic Polymeric Nanostructures Against Infectious Diseases
Li, X., Liu, S., Yin, P., & Chen, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.804416 · Cited by 6
Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
Parums, D. V. (2021) · Medical Science Monitor · doi:10.12659/msm.932915 · Cited by 7
A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice
Zeng, L., Zuo, Y., Tang, M., Lei, C., Li, H., Ma, X., Li, H., & Li, H. (2024) · iScience · doi:10.1016/j.isci.2024.111568 · Cited by 5
A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine
Liu, D., An, C., Bai, Y., Li, K., Liu, J., Wang, Q., He, Q., Song, Z., Zhang, J., Song, L., et al. (2022) · Viruses · doi:10.3390/v14091854 · Cited by 5
Analyzing research trends and patterns on COVID-19 vaccine hesitancy: A bibliometric study from 2021 to 2022
Sweileh, W. M. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13186 · Cited by 5
The protective role of maternal genetic immunization on maternal‐fetal health and welfare
Ahmed, S., Jiang, X., Liu, G., Yang, H., Sadiq, A., Yi, D., Farooq, U., Sha, Y., & Zubair, M. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14853 · Cited by 6
AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
Ahn, J., Yu, J. E., Kim, H., Sung, J., Han, G., Sohn, M. H., & Seong, B. L. (2023) · Toxins · doi:10.3390/toxins15070425 · Cited by 5
A Computationally Optimized Broadly Reactive Hemagglutinin and Neuraminidase Vaccine Boosts Antibody-Secreting Cells and Induces a Robust Serological Response, Preventing Lung Damage in a Pre-Immune Model
Ge, P., Mota, Y. C., Richardson, R. A., & Ross, T. M. (2024) · Vaccines · doi:10.3390/vaccines12070706 · Cited by 5
Current Perspectives on Viral Disease Outbreaks - Epidemiology, Detection and Control
Claborn, D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92485 · Cited by 5
Nano-Emulsion Incorporating Squalene and Mn2+ Stabilized by TA/Mn2+ Networks Enhances Subunit Vaccine Immunogenicity
Chen, K., Li, L., Wang, N., Deng, Y., Xiang, C., Zhang, X., Zhou, Y., Yang, H., Xie, Y., Chen, X., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s538737 · Cited by 4
TB and HIV induced immunosenescence: where do vaccines play a role?
Singh, M., Patel, B., Seo, M., Ahn, P., Wais, N., Shen, H., Nakka, S., Kishore, P., & Venketaraman, V. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1385963 · Cited by 5
Intranasal Drug Delivery of Antiviral Agents - A Revisit and Way Forward
Jino Affrald, R., & Narayan, S. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230727100812 · Cited by 4
Emerging Vaccine for the Treatment of Cancer via Nanotechnology
Foyez, T., Begum, Y., & Imran, A. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-35395-6_13 · Cited by 5
Application of gold nanoparticles in vaccine development
Farfán-Castro, S., García-Soto, M. J., Aguilar‐Aguilar, A., González‐Ortega, O., & Rosales‐Mendoza, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19061-2.00003-1 · Cited by 4
Drug discovery and development
Palanki, R., & Bose, S. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90300-4.00089-6 · Cited by 4
Efficacy, immunogenicity, and safety of BCG revaccination against Mycobacterium tuberculosis: A systematic review and meta-analysis
Sa, A., Shakir, S., Shaikh, U., Khalid, M., Jawed, M., Ali, S. I., Samo, M., Shariq, H., KHAN, M. M., Naeem, U., et al. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2630512 · Cited by 3
Synergizing immunity: lipid nanoparticle-mediated mRNA and gene delivery as a next-gen paradigm in cancer immunotherapy
Roy, A. A., Jain, N., Pokale, R., Madhusoodanan, G., Mukharya, A., Farhana, S. A., Rao, B. S. S., Goda, J. S., & Mutalik, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126862 · Cited by 4
Dendritic Mesoporous Silica Nanoparticle Adjuvants Modified with Binuclear Aluminum Complex: Coordination Chemistry Dictates Adjuvanticity
Yang, Y., Tang, J., Song, H., Yang, Y., Gu, Z., Fu, J., Liu, Y., Zhang, M., Qiao, Z., & Yu, C. (2020) · Angewandte Chemie · doi:10.1002/ange.202006861 · Cited by 3
InGaAs based gratings for UV–VIS spectrometer in prospective mRNA vaccine research
Ravindran, A., Nirmal, D., I.V, B. K. J., Pinkymol, K. P., Prajoon, P., & Ajayan, J. (2022) · Optical and Quantum Electronics · doi:10.1007/s11082-022-04002-1 · Cited by 3
Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
Adepoju, V. A., & Onyezue, O. I. (2023) · Breathe · doi:10.1183/20734735.0036-2023 · Cited by 3
Airway-applied mRNA vaccine needs tailored sequence design and high standard purification that removes devastating dsRNA contaminant
Zhang, J., Li, C., Liu, Y., Liao, R., He, D., Xu, L., Chen, T., Xiao, Q., Luo, M., Chen, Y., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.024 · Cited by 4
Let's Get Back to Normal? COVID-19 and the Logic of Cure
Berghs, M. J. (2022) · Frontiers in Sociology · doi:10.3389/fsoc.2022.782582 · Cited by 3
Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention
Akbar, R., Fatima, S., Rahman, S. U., Malik, A., Akhtar, S., Siddiqi, N. J., Aiman, S., & Huang, K. (2025) · Reviews in Medical Virology · doi:10.1002/rmv.70065 · Cited by 2
The experience of passive immunization against respiratory syncytial viral infection: the twelfth season
Mironova, A. K. (2022) · Russian Medical Inquiry · doi:10.32364/2587-6821-2022-6-11-659-666 · Cited by 2
Recombinant avian-derived antiviral proteins cIFITM1, cIFITM3, and cViperin as effective adjuvants in inactivated H9N2 subtype avian influenza vaccines
Yan, S., Chen, Y., Jin, L., Chen, H., Hu, C. J., Liu, H., Diao, H., Liu, S., & Chen, J. (2024) · Veterinary Microbiology · doi:10.1016/j.vetmic.2024.110277 · Cited by 2
Multi-modality imaging for precise intra-arterial delivery of mRNA, AAVs, and antibodies to the head and neck area in mice
Chu, C., Qiao, G., Madan, S., Fadon-Padilla, L., Wang, J., Salemdawod, A., Sharma, S., Gulisashvili, D., McDougall, L., Liang, Y., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113880 · Cited by 2
Vaccines from the perspective of a pharmacist
Franc, A. (2020) · Česká a slovenská farmacie · doi:10.36290/csf.2020.023 · Cited by 2
Amoeba-inspired magnetic microgel assembly assisted by engineered dextran-binding protein for vaccination against life-threatening systemic infection
Liu, S., Zhao, Y. G., Guo, L., & Yu, Q. (2022) · Nano Research · doi:10.1007/s12274-022-4809-1 · Cited by 2
The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants
Feng, S., Huang, M., Quan, Y., Sun, L., Lin, J., Zhang, D., Wei, X., Wang, Z., Ma, X., Wang, S., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110612 · Cited by 1
Klebsiella pneumoniae vaccines: Evolving the blueprint from traditional platforms to mucosal and nanoscale delivery
Hu, J., Xie, Y., Guan, W., Huang, L., & Li, X. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102919 · Cited by 1
First Insights into the Comparative Transcriptomic Response of Field and Laboratory Aedes aegypti Strains to Partial-Mortality Concentration (<50%) Imidacloprid and Broflanilide Exposure
Trujillo-Rodríguez, G. D. J., Martínez, M. G., Leal, J. A. F., Huerta-García, R. E., Ramírez‐Ahuja, M. D. L., Sánchez, I. P. R., & Fierro, M. D. L. L. M. (2026) · Insects · doi:10.3390/insects17020217 · Cited by 1
LNP-mRNA vaccines: Revolutionizing preventive medicine
Bhowmik, S., Kundu, S., Ghosh, S., Chowdhury, A. A., & Acharya, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45006-8.00007-0 · Cited by 1
Quantification of heterogeneity in human CD8+ T cell responses to vaccine antigens: an HLA-guided perspective
Harris, D. C., Shanker, A., Montoya, M. M., Llewellyn, T. R., Matuszak, A. R., Lohar, A., Kubicek-Sutherland, J. Z., Li, Y. W., Wilding, K. M., McMahon, B. H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1420284 · Cited by 1
COVID-19 as milestone for the use of new vaccine types
Marković, M. (2020) · Hrana i ishrana · doi:10.5937/hraish2001001m · Cited by 1
Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants
Dawood, A. A. (2022) · Vacunas (English Edition) · doi:10.1016/j.vacune.2022.10.012 · Cited by 1
Characterization of splenic and systemic immunity by differentially charged lipid adjuvants in enhancing post-intranasal immunization response against influenzaPreprint
Sengupta, A., Al-Otaibi, N., Devito, C., Lottersberger, F., & Hinkula, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2210670/v1 · Cited by 1
Airway applied IVT mRNA vaccine needs specific sequence design and high standard purification that removes devastating dsRNA contaminantPreprint
Zhang, J., Li, C., Liu, Y., Liao, R., He, D., Xu, L., Chen, T., Xiao, Q., Luo, M., Chen, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.22.614306 · Cited by 1
A Combined Adjuvant TF–Al Consisting of TFPR1 and Aluminum Hydroxide Augments Strong Humoral and Cellular Immune Responses in Both C57BL/6 and BALB/c Mice
Li, Q., Liu, Z., Liu, Y., Chen, L., Shu, J., Jin, X., Li, C., & Kou, Z. (2021) · Vaccines · doi:10.3390/vaccines9121408
Gut Microbiome and the Immune System
Guimaraes, H. I. P., de Jonge, J., van Baarle, D., & Fuentes, S. (2022) · Wiley eBooks · doi:10.1002/9781119762621.ch3
Anionic and Cationic Lipid Adjuvants individually induce distinct adaptive Th1/Th2-type immunity in enhancing post-intranasal immunization response against influenzaPreprint
Sengupta, A., Al-Otaibi, N., Devito, C., Lottersberger, F., & Hinkula, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2037306/v1
Recombinant Vaccines: The Revolution Ahead
Nayak, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_8
A Review of COVID-19 Vaccines, Immunogenicity, Safety, and Efficacy Toward Addressing Vaccine Hesitancy, Inequity, and Future Epidemic Preparedness
Puth, S., & Loeurng, V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003607
mRNA vaccines: a promising solution for incurable diseases
Ge, H., Hei, Y., & Wu, J. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3021657
Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization
Sengupta, A., Al-Otaibi, N., Devito, C., Lottersberger, F., & Hinkula, J. (2024) · Vaccines · doi:10.3390/vaccines12030320
Combination of multidisciplinary approaches reveals potential causal associations between influenza and immune cells: Single-cell RNA sequencing and Mendelian randomizationPreprint
Guo, Z., Wu, D., Chen, X., Wang, J., & Lv, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4276363/v1
12 Vaccine Candidates for Novel Pathogens
Bok, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-48408-7_14
Engineered Nanomaterials Chemical Characteristics for Cancer Immunotherapy
Islam, M. A., Chowdhury, M. S., Hasan, M. J., Rayhan, M. T., Islam, S., Hossain, N., & Mobarak, M. H. (2024) · Nano LIFE · doi:10.1142/s1793984424300127
Immunological enhancement of micro-nanoparticle formulated with risedronate and zinc as vaccine adjuvant in aged mice
Liu, Y., Yang, M., Nie, M., Wu, S., Su, R., Qiu, D., Lu, S., Xiong, H., Zhang, J., Ge, S., et al. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00512-0
Immunomodulating Agents
Furst, L. E., Hill, H. R., & Lapine, T. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00258-2
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?
Peghin, M., & Grossi, P. (2025) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001149
Nanotheranostic applications in pulmonary infections
Bueno, J. (2025) · Academia Medicine and Health · doi:10.20935/acadmed7934
Nanotheranostic applications in pulmonary infections
Bueno, J. (2025) · Academia Medicine and Health · doi:10.20935/acadmedhealth7934
Recombinant truncated gD glycoprotein from E.coli as a thermostable and protective subunit vaccine candidate against ILTV in chickens
Zhang, X., Li, Y., Tian, J., Zhang, M., Zhang, L., Zhang, G., & Zhao, Y. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127882
Development of a High-Hydrostatic-Pressure-Treated Recombinant Vaccine Targeting the Major Capsid Protein of Red Sea Bream Iridovirus
Sawasaki, Y., Harakawa, S., Kitamura, S., Terawaki, N., Zhu, Z., Yamada, K., Fujisaki, H., Hirano, S., Hamada, M., Miyakawa, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020675
Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects
Chandpa, H. H., Ruchika, Naskar, S., Saneja, A., & Meena, J. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104647
Séroprévalence des anticorps neutralisants dirigés contre les adénovirus de types C5, D26 et B35 au Burkina Faso et au Tchad : impacts sur l’utilisation de vecteurs dérivés des Adénovirus dans un contexte de vaccination
Ouoba, T. (2021) · doi:10.70675/2191bb60zcd55z42a3zb9ddz096fdace9d13
Spore surface display of Chinook salmon bafinivirus (CSBV) nucleoprotein in Bacillus subtilis as an oral vaccine candidate for Japanese flounder Paralichthys olivaceus
ZHANG, Y., Wang, G., LIU, Y. F., He, Z., He, Z., Han, T., Ren, Y., & Hou, J. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111426
Introduction: Socio-technological Relationships in Vaccine Systems—Innovation, Production, Distribution, and Equity
Adekola, T. A., & Nadh, P. O. (2026) · Springer eBooks · doi:10.1007/978-981-95-8349-2_1
Biotechnology in vaccine development: mRNA, protein-based vaccines, and oligonucleotides in drug delivery
Verma, A., Sindhu, S. R., Boora, N., Garg, B., Yashveer, S., & Vinchurkar, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40620-1.00007-8
Sustained degradation of glucose transporter 1 by an mRNA-encoded lysosome-targeting chimera triggers metabolic collapse and pyroptosis in cancer
Chang, X., Qiu, X., Tong, X., Shi, Y., Jia, H., Zuo, C., Xie, S., Gan, S., & Tan, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115450
Advanced strategies for enhancing mRNA-lipid nanoparticles stability: molecular insights, stabilization techniques, and clinical applications
Prinindya, K. N. N., Pokharel, S., & Mahdi, E. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127561
COBRA HA and NA vaccine boosts antibody-secreting cells and induces serological response.
Ross, T. (2025) · ImmPort · doi:10.21430/m30bops0te
Rationally Designed TLR2-QS-21 Liposomal Adjuvant Enhances Immunogenicity while Reducing Reactogenicity in Subunit Vaccines
Ma, W., Tang, R., Wang, H., Jia, H., Wang, Y., Zhou, S., Lv, T., & Wang, X. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02716

Authors: Mascola, J. R., & Fauci, A. S.
Affiliations: National Institutes of Health (US)
Corresponding author: Fauci, Anthony S.
ORCID: Mascola, John R.
Fauci, Anthony S.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2019-11-11
Volume: 20
Issue: 2
Pages: 87-88
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/s41577-019-0243-3
PMC: PMC7222935
OpenAlex: W2983736730
Cited by: 171
References: 10
Citations by year: 2026: 13 · 2025: 24 · 2024: 33 · 2023: 24 · 2022: 35 · 2021: 24 · 2020: 17 · 2019: 1
FWCI: 7.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords: vaccine development, gene-based vaccines, tuberculosis vaccine, influenza vaccination, RSV vaccine, adjuvant development
MeSH terms: Drug Development, Adjuvants, Immunologic, BCG Vaccine, Humans, Influenza, Human, Influenza Vaccines, Recombinant Proteins, RNA, Messenger, Vaccines, Vaccines, Synthetic, Viral Fusion Proteins, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Tuberculosis Vaccines, Latent Tuberculosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Novel vaccine technologies for the 21st century

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks